Core Viewpoint - Minsheng Health is in the initial stage of launching its new smoking cessation product, Minsheng Lesuke, which is currently available for pre-sale on various e-commerce platforms and is gradually being introduced in offline pharmacies [1] Group 1: Product Launch and Promotion - The new product, Minsheng Lesuke (varenicline tartrate), is being promoted through multiple channels including e-commerce platforms and offline pharmacies [1] - The product has officially started pre-sale on platforms such as JD Health and Alibaba Health, with ongoing efforts to list it in offline pharmacies [1] Group 2: Collaboration and Health Education - The company is collaborating with authoritative smoking cessation organizations to conduct educational initiatives aimed at enhancing consumer health awareness [1] - In August 2025, the company, in partnership with the China Smoking Control Association, released the "China Clinical Smoking Cessation Expert Consensus Gold Standard (2025 Updated Version)" [1] - In November 2025, the company co-founded a Health Promotion Professional Committee with the China Smoking Control and Health Association [1] Group 3: Commitment to Public Health - As an active participant in public health services, the company plans to collaborate with relevant authoritative institutions to advance academic research, standard formulation, and health education [1] - The company aims to contribute to the establishment of a more comprehensive smoking control system and support the construction of a healthy China through its pharmaceutical efforts [1]
民生健康(301507.SZ)：民生乐速克酒石酸伐尼克兰片在京东健康、阿里健康等线上平台已正式开启预售